Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Immune Dysregulation and Community Health Factors in Maternal and Childhood Leprosy: A Partial Least Squares-Structural Equation Modelling Study

Prakoeswa FRS, Endaryanto A, Prakoeswa CRS. XMLink. Infection & Chemotherapy. 2026; 58 (2) : 224.
Download PDF
Publication

The psychosocial impact of disability and stigma among persons affected by leprosy and lymphatic filariasis in India

van Wijk R, Agarwal A, Nayak P, et al. PLOS mental health. 2026; 3 (7) : 1 - 16.
Download PDF
Publication

Prevalence and Associated Risk Factors of Urinary Schistosomiasis in Al Managil City, Gezira State, Sudan: A Cross‐Sectional Study

Ahmed MASM, Mohammedahmed HIH, Ahmed AGA, et al. Wiley. Health Science Reports. 2026; 9 (6) : 1 - 10.
Download PDF
Publication

GD06 Single-dose rifampicin for control of leprosy transmission: rollout and navigating funding challenges in Nepal

Baskota R, Sunar C. Oxford University Press (OUP). British Journal of Dermatology. 2026; 195 (Supplement_1) : 1 - 2.
Download PDF
Publication

Long-term disability outcomes in Hansen's disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy

Ma E, Adler B, Armstrong A, et al. PLoS neglected tropical diseases. 2026; 20 (6) : 1 - 6.
Download PDF
Publication

Exploring pediatric leprosy in an endemic area: Case series of eight patients in Indonesia

Gitalisa Andayani Adriono , Tri Rahayu , Sri Linuwih SW Menaldi , et al. Universitas Indonesia. Journal of General - Procedural Dermatology and Venereology Indonesia. 2026; 10 (1) : 1 - 12.
Download PDF
Publication

Perforating lepromatous leprosy presenting as a generalised papulonecrotic eruption

Kumar A, Selvaraj R, Badajena P, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2026;
Download PDF
Publication

Clinico-sonological study of peripheral nerve involvement in leprosy in a tertiary care medical center, India

Mohan A, MG S, Kunjumani S. Springer Science and Business Media LLC. Journal of Rare Diseases. 2026; 5 (1) : 1 - 8.
Download PDF
Publication

Socioeconomic determinants of leprosy in Brazilian municipalities: an ecological study

Golineli A, Belli M, Lourenço G, et al. Anais brasileiros de dermatologia. 2026; 101 (4) : 1 - 5.
Download PDF
Publication

Progress towards elimination of leprosy in the Eastern Mediterranean Region

Warusavithana S, Osman M, Saleh B, et al. World Health Organization Regional Office for the Eastern Mediterranean (WHO/EMRO). Eastern Mediterranean Health Journal. 2026; 32 (2) : 115 - 124.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD